424 related articles for article (PubMed ID: 29409452)
1. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
[TBL] [Abstract][Full Text] [Related]
2. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
3. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
[TBL] [Abstract][Full Text] [Related]
4. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.
Madhavan D; Zucknick M; Wallwiener M; Cuk K; Modugno C; Scharpff M; Schott S; Heil J; Turchinovich A; Yang R; Benner A; Riethdorf S; Trumpp A; Sohn C; Pantel K; Schneeweiss A; Burwinkel B
Clin Cancer Res; 2012 Nov; 18(21):5972-82. PubMed ID: 22952344
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
7. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
9. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
[TBL] [Abstract][Full Text] [Related]
11. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
Braicu C; Raduly L; Morar-Bolba G; Cojocneanu R; Jurj A; Pop LA; Pileczki V; Ciocan C; Moldovan A; Irimie A; Eniu A; Achimas-Cadariu P; Paradiso A; Berindan-Neagoe I
J Exp Clin Cancer Res; 2018 Oct; 37(1):257. PubMed ID: 30342533
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
[TBL] [Abstract][Full Text] [Related]
14. Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
Akkiprik M; Koca S; Uğurlu MÜ; Ekren R; Peker Eyüboğlu İ; Alan Ö; Erzik C; Güllü Amuran G; Telli TA; Güllüoğlu MB; Sezerman U; Yumuk PF
Clin Breast Cancer; 2020 Aug; 20(4):332-343.e3. PubMed ID: 32201164
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
[TBL] [Abstract][Full Text] [Related]
16. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
17. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
18. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
Zhao S; Yao D; Chen J; Ding N
Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
[TBL] [Abstract][Full Text] [Related]
19. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
20. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]